Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Boehringer Ingelheim
Moodys
McKesson
Medtronic

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for Biogen Idec, Inc. v. Glaxosmithkline LLC (S.D. Cal. 2010)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Biogen Idec, Inc. v. Glaxosmithkline LLC (S.D. Cal. 2010)

Docket   Start Trial Date Filed 2010-03-24
Court District Court, S.D. California Date Terminated 2011-11-15
Cause 35:0145 Civil Action to Obtain Patent Assigned To Roger T. Benitez
Jury Demand Defendant Referred To Magistrate Judge Bernard G. Sk
Parties BIOGEN IDEC, INC.; GENENTECH, INC.; GLAXO GROUP LIMITED; GLAXOSMITHKLINE LLC
Patents 4,001,323; 5,736,137; 5,776,456; 5,843,439; 6,399,061; 6,682,734; 7,682,612
Attorneys Andrea C. Hutchison; Brian W. Nolan; Elizabeth Mann; Erica Pascal; Henry C Su; John Allcock; Kathryn Bridget Riley; Lisa M. Ferri; Richard J. McCormick; Robert M. Galvin; Vera A. Nackovic
Link to Docket External link to docket
Small Molecule Drugs cited in Biogen Idec, Inc. v. Glaxosmithkline LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in Biogen Idec, Inc. v. Glaxosmithkline LLC

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Biogen Idec, Inc. v. Glaxosmithkline LLC (S.D. Cal. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-03-23 1 lymphorms. Byrd J.C. Cancer Blatlr`én Rcdlaphdrm. 14(4)1. 323. 1999. Ritwtimsb therapy in patients with chronic… United States Patent (10) PatentNo.: US 7,682,612 Bl White et al. (45) Date of Patent: Mar. 23, 2010 … for declaratory judgment of patent infringement of United States Patent No. 7,682,612. This action arises… for declaratory judgment of patent infringement arising under the patent laws of the United States 35… the United States Patent and Trademark Office duly and legally issued U.S. Patent No. 7,682,612 (" External link to document
2010-03-23 3 or determination of an action regarding patent number *7,682,612* (ecs) (kaj). (Entered: 03/25/2010) … 15 November 2011 3:10-cv-00608-BEN-BGS Patent Defendant District Court, S.D External link to document
2011-10-18 60 Plaintiffs point to U.S. Patent No. 5,736,137, incorporated by reference into the ’612 patent at 3 :23-24. (Pascal…-55.) ._n L») Defendants point to U.S. Patent No. 5,736,137, which is incorporated by reference into…applied for U.S. Patent No. 7,682,612, which was approved on March 23, 2010. The ’612 patent claims methods… in the ’612 patent. DISCUSSION I. LEGAL STANDARD “It is a bedrock principle of patent law that the…consider the patent’s prosecution history, which is the record of proceedings before the Patent and Trademark External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Baxter
Medtronic
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.